The world of life sciences and marketing as a whole are evolving at lightning speed. In recent years, it has become more status quo that if you strive to be current, you'll probably always be behind. That's how fast our world is changing. Now, more than ever, marketers and related functions not only have to be more swift and agile, they are required to do more with less. By attending CBI's iPharma 2015 you and your teams will learn to stay ahead of the market, by creating needs rather than responding to them. Here are six reasons as to why iPharma 2015 should be your Life Sciences Marketing event of choice: Read More
CBI Scene Blog
Topics: Brand & Digital Strategy
In recent years, corporations have taken the challenge to address health and wellness head on in the business environment. Companies collectively spend billions of dollars every year promoting exercise and nutrition, and the pay-off is often extraordinary. Employees everywhere are getting healthy and having fun doing it. Unfortunately, employees who travel often sometimes get the short end of the stick. From spending hours in a car or on a plane to missing in-office health challenges and the accompanying rewards, employees who travel have little to no company-inspired incentive to pursue good health.Read More
Topics: Meeting Management
As global health care providers (HCPs) focus on transparency to deliver quality care, it has become more complex than simply targeting high-level care. A recent study by international consulting firm, Deloitte Consulting LLP, generated interesting results for global life sciences organizations. U.S. pharmaceutical companies have experience dealing with transparency regulations for some time.Read More
We want to spread our joy to the world and tell you that the Pharma Forum 2015 agenda is hot off the press! We have a lot of new things happening this year and hope you are looking as forward to this longest-running industry-leading event as much as we are! Here are ten things to cross-off your wish list this year:Read More
Topics: Meeting Management
People living with rare diseases face unique obstacles that stand in the way of their treatment. Because a rare disease affects less than 200,000 Americans, these diseases can go largely unrecognized – even amongst health care providers. Technological developments and the expansion of online communities are helping to raise awareness by providing new opportunities for networking and valuable resources for patients and professionals alike.
Tracking down participants for clinical trials can be difficult and trials often occur far from patients’ homes, but drug developers are beginning to use online sharing and social media to spread the word to target communities. Individuals within these communities are also spreading the word and helping to increase involvement in trials where new treatments are in high demand. Because only about 400 approved treatments exist for rare diseases, there is pressure for new medicines to be produced quickly and most development timelines are condensed. The drugs that meet FDA criteria are released and provide great relief to a small market. However, the shortened timeline can increase the opportunity for error to occur outside of the trial and limits the amount of time for observations to ensure a drug’s maximum efficacy.Read More
Topics: Patient Access
The medical sciences field comes with a wide range of uphill battles. There are about a million different issues and one major issue is open payment disputes. It is always helpful to identify those individuals in a company that are going to be able to help deal with open payments disputes. These individuals should be skilled in dealing with issues quickly and easily to help make the process run smoothly.Read More
The March 31, 2014 deadline for submitting reports reflecting the financial relationships between biotech companies, group-purchasing organizations (GPOs), pharmaceutical companies and medical device manufacturers passed. Physicians now have 45-days to review the reports for errors before the Centers for the Medicare and Medicaid Services (CMS) database goes online.
The Medicaid and Government Pricing Congress is one of the industry’s largest gatherings of managers and executives responsible for Contracts, Pricing, Finance, Accounting and Government Program Compliance. Over the past 15 years, almost 3,000 attendees have benefited from this valuable conference, which brings real world topics — including Healthcare Reform, Medicaid Expansion, Exchanges, Gross-to-Net, VA/DoD, 340B and Compliance — all into one forum. The session content and quality of presenters are always outstanding, and the opportunities to network with industry peers are invaluable.